Free Trial

Perrigo (PRGO) Stock Price, News & Analysis

Perrigo logo
$23.92 +0.19 (+0.78%)
Closing price 03:59 PM Eastern
Extended Trading
$23.89 -0.02 (-0.10%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Perrigo Stock (NYSE:PRGO)

Key Stats

Today's Range
$23.70
$24.04
50-Day Range
$22.04
$28.41
52-Week Range
$21.03
$30.93
Volume
1.19 million shs
Average Volume
1.48 million shs
Market Capitalization
$3.29 billion
P/E Ratio
N/A
Dividend Yield
4.85%
Price Target
$33.00
Consensus Rating
Hold

Company Overview

Perrigo Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
100th Percentile Overall Score

PRGO MarketRank™: 

Perrigo scored higher than 100% of companies evaluated by MarketBeat, and ranked 10th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Perrigo has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Perrigo has only been the subject of 2 research reports in the past 90 days.

  • Read more about Perrigo's stock forecast and price target.
  • Earnings Growth

    Earnings for Perrigo are expected to grow by 19.53% in the coming year, from $2.56 to $3.06 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Perrigo is -41.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Perrigo is -41.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Perrigo has a P/B Ratio of 0.74. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Perrigo's valuation and earnings.
  • Percentage of Shares Shorted

    4.17% of the float of Perrigo has been sold short.
  • Short Interest Ratio / Days to Cover

    Perrigo has a short interest ratio ("days to cover") of 4.3.
  • Change versus previous month

    Short interest in Perrigo has recently decreased by 10.09%, indicating that investor sentiment is improving significantly.
  • Dividend Leadership

    Perrigo is a leading dividend payer. It pays a dividend yield of 4.88%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Perrigo has been increasing its dividend for 23 years.

  • Dividend Sustainability

    Based on earnings estimates, Perrigo will have a dividend payout ratio of 37.91% next year. This indicates that Perrigo will be able to sustain or increase its dividend.

  • Read more about Perrigo's dividend.
  • Percentage of Shares Shorted

    4.17% of the float of Perrigo has been sold short.
  • Short Interest Ratio / Days to Cover

    Perrigo has a short interest ratio ("days to cover") of 4.3.
  • Change versus previous month

    Short interest in Perrigo has recently decreased by 10.09%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Perrigo has a news sentiment score of 1.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.97 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 15 news articles for Perrigo this week, compared to 7 articles on an average week.
  • Search Interest

    Only 1 people have searched for PRGO on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added Perrigo to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Perrigo insiders have bought more of their company's stock than they have sold. Specifically, they have bought $204,575.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 0.40% of the stock of Perrigo is held by insiders.

  • Percentage Held by Institutions

    95.91% of the stock of Perrigo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Perrigo's insider trading history.
Receive PRGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Perrigo and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PRGO Stock News Headlines

Perrigo (NYSE:PRGO) EVP Robert Willis Buys 1,488 Shares
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.tc pixel
STATE STREET CORP Increases Stake in Perrigo Co PLC
See More Headlines

PRGO Stock Analysis - Frequently Asked Questions

Perrigo's stock was trading at $25.71 at the start of the year. Since then, PRGO shares have decreased by 7.0% and is now trading at $23.9150.

Perrigo Company plc (NYSE:PRGO) posted its quarterly earnings results on Wednesday, August, 6th. The company reported $0.57 earnings per share for the quarter, missing analysts' consensus estimates of $0.59 by $0.02. The firm's revenue for the quarter was down .9% compared to the same quarter last year.
Read the conference call transcript
.

The following companies are subsidiaries of Perrigo: HRA Pharma, Ranir, Laboratoire de la Mer SAS, Geiss Destin & Dunn, ScarAway, Omega Pharma, Elan Corporation, and others.

Top institutional shareholders of Perrigo include State Street Corp (5.34%), Ion Asset Management Ltd. (2.77%), Cooke & Bieler LP (2.40%) and Sound Shore Management Inc CT (2.39%). Insiders that own company stock include Svend Andersen, Eduardo Guarita Bezerra, Robert Willis, Ronald Craig Janish, Geoffrey M Parker, James E Dillard III, Patrick Lockwood-Taylor, Alison Ives, Grainne Quinn, Katherine C Doyle, Jeffrey B Kindler, Thomas Farrington and Murray S Kessler.
View institutional ownership trends
.

Shares of PRGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Perrigo investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Advanced Micro Devices (AMD), ServiceNow (NOW) and Arista Networks (ANET).

Company Calendar

Record date for 6/17 Dividend
5/30/2025
Ex-Dividend for 6/17 Dividend
5/30/2025
Dividend Payable
6/17/2025
Last Earnings
8/06/2025
Today
8/27/2025
Record date for 9/16 Dividend
8/29/2025
Ex-Dividend for 9/16 Dividend
8/29/2025
Dividend Payable
9/16/2025
Next Earnings (Estimated)
11/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceuticals
Current Symbol
NYSE:PRGO
CIK
1585364
Employees
8,379
Year Founded
1887

Price Target and Rating

High Price Target
$40.00
Low Price Target
$27.00
Potential Upside/Downside
+38.8%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.58)
Trailing P/E Ratio
N/A
Forward P/E Ratio
9.29
P/E Growth
N/A
Net Income
-$171.80 million
Net Margins
-1.86%
Pretax Margin
2.39%
Return on Equity
9.09%
Return on Assets
3.96%

Debt

Debt-to-Equity Ratio
0.81
Current Ratio
2.32
Quick Ratio
1.24

Sales & Book Value

Annual Sales
$4.37 billion
Price / Sales
0.75
Cash Flow
$5.05 per share
Price / Cash Flow
4.71
Book Value
$32.51 per share
Price / Book
0.73

Miscellaneous

Outstanding Shares
137,580,000
Free Float
137,033,000
Market Cap
$3.27 billion
Optionable
Optionable
Beta
0.47

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NYSE:PRGO) was last updated on 8/27/2025 by MarketBeat.com Staff
From Our Partners